Tavo Biotherapeutics
Develops novel therapeutics for glaucoma and retinal diseases
$17MSeries A
Role not disclosedActivity from announced rounds
Develops novel therapeutics for glaucoma and retinal diseases
Atmospheric water-generation systems and packaged drinking water, with production, bottling and distribution operations.